Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The association between DEF8 and melanoma is supported by two independent large-scale studies that have leveraged genome‑wide association methodologies to prioritize novel susceptibility genes. In the first study, a meta‑analysis involving 15,990 melanoma cases and 26,409 controls demonstrated an extremely significant association for DEF8 (P = 1.09 × 10^-57 (PMID:31630191)), underpinning its potential role in melanoma predisposition. The second study, which examined gene‐environment interactions in 1,563 melanoma cases and 193,296 controls, further substantiated the involvement of DEF8 in melanoma risk with statistically significant findings (PMID:34724200).
While the mode of inheritance for high‐penetrance melanoma genes is often autosomal dominant, the association of DEF8 with melanoma represents a susceptibility locus where variants likely confer modest risk in a multifactorial context. No familial segregation data or clearly defined causative coding variants were reported in these studies, suggesting that the primary evidence for this gene–disease relationship stems from population-level statistical associations. As a result, no standardized HGVS coding variant for DEF8 was provided; however, the strength of the association is not diminished by the lack of a single “causal” variant.
Genetic evidence for DEF8 is bolstered by robust statistics across multiple cohorts. The meta‑analysis demonstrating a remarkably significant p‑value (PMID:31630191) and the gene–environment interaction study (PMID:34724200) collectively provide strong genetic evidence despite the absence of classic Mendelian segregation patterns. The large sample sizes and consistency of findings across independent studies underscore the gene’s contributory role in melanoma risk.
Functional annotation using tools such as FUMA has implicated DEF8 in regulatory networks relevant to melanoma. Although there is no detailed report of experimental rescue or animal models, the integration of chromatin interaction mapping and expression quantitative trait locus analyses supports a mechanistic role for DEF8 in modulating gene expression in melanoma-relevant tissues. This functional evidence, while indirect, is concordant with the genetic association data and lends moderate support to the gene–disease relationship.
There is currently no conflicting evidence that weakens the association between DEF8 and melanoma. Both studies converge on the finding that DEF8 merits inclusion in the list of melanoma susceptibility genes, with statistical outcomes that far exceed conventional significance thresholds. Nonetheless, further experimental work is needed to elucidate the precise biological mechanism through which DEF8 influences melanoma risk.
In conclusion, the integration of large-scale genetic data and functional annotations robustly supports a strong association between DEF8 and melanoma. This association, despite relying on non-Mendelian statistical associations rather than classic segregation studies or coding variant analysis, holds significant potential to improve risk stratification and inform future diagnostic decision-making in melanoma.
Gene–Disease AssociationStrongThe association is supported by extremely significant p-values from a meta-analysis of 15,990 cases (PMID:31630191) and independent gene–environment studies involving 1,563 cases (PMID:34724200). Genetic EvidenceStrongMultiple large cohorts demonstrate robust statistical support for DEF8, with consistent results across independent studies. Functional EvidenceModerateFunctional mapping and chromatin interaction analyses implicate DEF8 in melanoma-relevant regulatory networks, providing supportive experimental evidence. |